wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47932240-0D9C6271-CFD0-4BEC-9C5F-EC0BB06EEFF6
Q47932240-0D9C6271-CFD0-4BEC-9C5F-EC0BB06EEFF6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47932240-0D9C6271-CFD0-4BEC-9C5F-EC0BB06EEFF6
Novel synthetic drugs currently in clinical development for chronic lymphocytic leukemia.
P2860
Q47932240-0D9C6271-CFD0-4BEC-9C5F-EC0BB06EEFF6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47932240-0D9C6271-CFD0-4BEC-9C5F-EC0BB06EEFF6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4be1085da2fa16a68e1e88d8ecb00c16e53b60e5
P2860
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies